GEN Exclusives

More »

GEN News Highlights

More »
Apr 16, 2008

Bio-Bridge and JRS to Form a Joint Venture for Biomaterial Supply in China

  • Bio-Bridge Science and JR Scientific report plans to invest RMB 10 million, or $1.43 million, to set up a joint venture that will supply biomaterials in China and other countries.

    The firms signed a a nonbinding memorandum of understanding to effect the formation of the JV, which will be carried out with other investors in China. JRS has agreed to transfer technology and know-how to the JV. The new entity will produce culture medium, serum, and other biomaterials for sale.

    The JV will serve as a source of revenue for Bio-Bridge. With an HIV-PV vaccine for prevention and treatment of HIV in preclinical testing, Bio-Bridge will also gain a new supplier for the relevant vaccine material.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Block That Microbiome Metaphor!

Which way of thinking about the microbiome would best integrate the virome’s contributions?